James P. Shaffer
2011
In 2011, James P. Shaffer earned a total compensation of $1.2M as Vice President and Chief Commercial Officer at Halozyme Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $35,000 |
|---|---|
| Option Awards | $982,940 |
| Salary | $120,705 |
| Other | $16,180 |
| Total | $1,154,825 |
Shaffer received $982.9K in option awards, accounting for 85% of the total pay in 2011.
Shaffer also received $35K in non-equity incentive plan, $120.7K in salary and $16.2K in other compensation.
Rankings
In 2011, James P. Shaffer's compensation ranked 5,133rd out of 10,747 executives tracked by ExecPay. In other words, Shaffer earned more than 52.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,133 out of 10,747 | 52nd |
Division Manufacturing | 1,856 out of 3,960 | 53rd |
Major group Chemicals And Allied Products | 395 out of 1,038 | 62nd |
Industry group Drugs | 244 out of 786 | 69th |
Industry Biological Products, Except Diagnostic Substances | 40 out of 162 | 75th |
Source: SEC filing on April 7, 2014.
Shaffer's colleagues
We found six more compensation records of executives who worked with James P. Shaffer at Halozyme Therapeutics in 2011.
2011
Jean Liu
Halozyme Therapeutics
General Counsel
2011
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2011
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2011
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2011
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2011
David Ramsay
Halozyme Therapeutics